Second TMR (transmyocardial revascularisation) device wins strong backing from FDA committee
This article was originally published in Clinica
Eclipse Surgical Technologies last week won backing from an FDA panel for its transmyocardial revascularisation (TMR) system, while receiving nothing but praise on its clinical data.
You may also be interested in...
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.
Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.